Current issues in allogeneic islet transplantation

@article{Chang2017CurrentII,
  title={Current issues in allogeneic islet transplantation},
  author={Charles A. Chang and M. Lawrence and B. Naziruddin},
  journal={Current Opinion in Organ Transplantation},
  year={2017},
  volume={22},
  pages={437–443}
}
Purpose of review Transplantation of allogenic pancreatic islets is a minimally invasive treatment option to control severe hypoglycemia and dependence on exogenous insulin among type 1 diabetes (T1D) patients. This overview summarizes the current issues and progress in islet transplantation outcomes and research. Recent findings Several clinical trials from North America and other countries have documented the safety and efficacy of clinical islet transplantation for T1D patients with impaired… Expand
Clinical islet transplantation: is the future finally now?
A comparison of the inflammatory response following autologous compared with allogenic islet cell transplantation.
Transplantation routes affect the efficacy of human umbilical cord mesenchymal stem cells in a rat GDM model.
...
1
2
...

References

SHOWING 1-10 OF 82 REFERENCES
Clinical islet transplantation: advances and immunological challenges
Current indications for pancreas or islet transplant
Potent Induction Immunotherapy Promotes Long‐Term Insulin Independence After Islet Transplantation in Type 1 Diabetes
  • M. Bellin, F. Barton, +6 authors B. Hering
  • Medicine
  • American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons
  • 2012
Financial Issues Constraining the Use of Pancreata Recovered for Islet Transplantation: A White Paper
...
1
2
3
4
5
...